Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer

Y Gao, S Zhou, Y Xu, S Sheng, SY Qian, X Huo - Nitric Oxide, 2019 - Elsevier
Background It has been widely accepted that angiogenesis plays fundamental roles in
colorectal cancer development, and therapeutic targeting of this pathway has achieved …

Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses

R Li, Y Song, Z Ji, L Li, L Zhou - Biofactors, 2020 - Wiley Online Library
This article was designed by using a network pharmacological approach to reveal the
therapeutic targets and molecular mechanisms of oxyresveratrol (Oxyres) treating colorectal …

[HTML][HTML] Microenvironmental reactive oxygen species in colorectal cancer: involved processes and therapeutic opportunities

MA Sorolla, I Hidalgo, A Sorolla, R Montal, O Pallisé… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer is a disease associated with a high mortality rate. During
the tumorigenic process, several factors and signaling molecules produced by tumor cells …

Reactive oxygen species mediate oxaliplatin-induced epithelial-mesenchymal transition and invasive potential in colon cancer

L Jiao, DD Li, CL Yang, RQ Peng, YQ Guo, XS Zhang… - Tumor Biology, 2016 - Springer
Therapeutic benefits offered by common chemotherapy drugs, such as oxaliplatin, are
limited due to the development of resistance, which contributes to treatment failure and …

The role of inflammation in colon cancer

NB Janakiram, CV Rao - Inflammation and cancer, 2014 - Springer
Colorectal cancer (CRC) is the one of the leading causes of cancer-related deaths in the
world. CRC is responsible for more than 600,000 deaths annually and incidence rates are …

Targeting the L-arginine-nitric oxide pathway for cancer treatment

Q Ma, Z Wang, M Zhang, H Hu, J Li… - Current …, 2010 - ingentaconnect.com
The action of L-arginine is mainly dependent on its end-product, nitric oxide (NO). The L-
arginine/NO pathway has been confirmed to play an important role in tumor development …

[HTML][HTML] Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool

DG Brown, S Rao, TL Weir, J O'Malia, M Bazan… - Cancer & …, 2016 - Springer
Background Colorectal cancers (CRC) are associated with perturbations in cellular amino
acids, nucleotides, pentose-phosphate pathway carbohydrates, and glycolytic …

[HTML][HTML] The role of oxidative stress and its counteractive utility in colorectal cancer (CRC)

D Basak, MN Uddin, J Hancock - Cancers, 2020 - mdpi.com
Simple Summary Colorectal cancer (CRC) is very common throughout the world. Despite an
improved outcome with the current treatment regimen, a huge number of patients relapse …

[HTML][HTML] Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer

T Jayakrishnan, A Mariam, N Farha, DM Rotroff… - Scientific Reports, 2024 - nature.com
Deleterious effects of environmental exposures may contribute to the rising incidence of
early-onset colorectal cancer (eoCRC). We assessed the metabolomic differences between …

[HTML][HTML] Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

AC Nirvanappa, CD Mohan, S Rangappa, H Ananda… - PLoS …, 2016 - journals.plos.org
Aberrant activation of nuclear factor kappa B (NF-κB) has been linked with the pathogenesis
of several proinflammatory diseases including number of cancers and inflammatory bowel …